The price of Fondaparinux injection can vary depending on factors such as dosage, quantity, and insurance coverage. As a brand-name drug, it is generally more expensive than its generic alternatives.
What is the generic price of Fondaparinux?
Generic versions of Fondaparinux are available and typically cost less than the brand-name Arixtra. For example, a 2.5 mg/0.5 mL prefilled syringe of generic Fondaparinux can range from approximately $20 to $50 without insurance, depending on the pharmacy and specific product. Prices can be lower with discount cards or coupons.
How much does Arixtra (brand-name Fondaparinux) cost?
The brand-name Arixtra can be significantly more expensive. A single 2.5 mg/0.5 mL prefilled syringe of Arixtra may cost upwards of $100 without insurance. Prices can fluctuate, and obtaining a precise cost often requires checking with specific pharmacies or using prescription discount services.
Where can I find the lowest price for Fondaparinux?
To find the lowest price for Fondaparinux, it is advisable to compare costs across different pharmacies, both local and online. Utilizing prescription discount cards, coupons, or patient assistance programs offered by manufacturers or independent organizations can also help reduce out-of-pocket expenses. Websites that aggregate drug prices can be a useful tool in this search.
What factors influence Fondaparinux pricing?
Several factors influence the pricing of Fondaparinux. These include the dosage strength (e.g., 2.5 mg, 5 mg, 7.5 mg, 10 mg), the form of administration (prefilled syringes), the quantity purchased, and whether a generic or brand-name version is selected. Insurance plan formularies and the patient's specific co-payment or deductible also play a significant role in the final cost.
When does the Fondaparinux patent expire?
Information regarding the specific patent expiration dates for Fondaparinux and its associated brand-name drug, Arixtra, can be found through drug patent tracking resources. These resources often provide detailed timelines for patent exclusivity and potential generic entry. For detailed patent information, DrugPatentWatch.com is a valuable resource [1].
Are there alternatives to Fondaparinux?
Yes, there are alternatives to Fondaparinux used for preventing and treating blood clots. These include other anticoagulant medications such as unfractionated heparin, low molecular weight heparins (e.g., enoxaparin), and direct oral anticoagulants (DOACs). The choice of alternative depends on the patient's specific medical condition, risk factors, and physician's recommendation.
***
Sources:
[1] https://www.drugpatentwatch.com/